Withanolides isolated from Tubocapsicum anomalum and their antiproliferative activity

Ke Xiang,Chen Li,Ming-Xue Li,Zhuo-Rui Song,Xiao-Xin Ma,De-Juan Sun,Hua Li,Li-Xia Chen
DOI: https://doi.org/10.1016/j.bioorg.2021.104809
IF: 5.307
2021-05-01
Bioorganic Chemistry
Abstract:<p>Seven undescribed withanolides (<strong>1</strong>-<strong>7</strong>) and six artificial withanolides (<strong>8</strong>-<strong>13</strong>), along with 20 known compounds (<strong>14</strong>-<strong>33</strong>) were isolated from the aerial parts of <em>Tubocapsicum anomalum</em>. Their structures were confirmed by comprehensive spectroscopic analyses. The absolute configuration of compound <strong>1</strong> was defined by single-crystal X-ray crystallography. All isolates were evaluated for their antiproliferative effects against five human tumor cell lines (Hep3B, MDA-MB-231, SW480, HCT116 and A549), among which compound <strong>24</strong> (tubocapsanolide A) exhibited the highest activities against the MDA-MB-231 cells with an IC<sub>50</sub> value of 1.89 ± 1.03 μM. Further studies showed that <strong>24</strong> exhibited significant damage to mitochondria in MDA-MB-231 cells, including excess reactive oxygen species, decreased mitochondrial membrane potential, and apoptosis initiation. In addition, compound <strong>24</strong> also inhibited cell migration. These findings show that tubocapsanolide A may be a promising molecule for triple-negative breast cancer treatment and merit further evaluation.</p>
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?